Full-Time

Pharmacovigilance Quality Assurance Lead

Confirmed live in the last 24 hours

Zoetis

Zoetis

5,001-10,000 employees

Develops and sells animal health products

No salary listed

Senior

Kalamazoo, MI, USA

In Person

Category
QA & Testing
Quality Assurance
Requirements
  • Bachelor’s Degree or equivalent in biology, animal science or other relevant science field.
  • Demonstrated relevant auditing experience (minimum 5 years) in veterinary pharmacovigilance or related regulatory environment.
  • Experience with deviation/CAPA processes and associated documentation.
  • Experience in managing people.
  • High level of competency using Microsoft Office suite (e.g., Word, Excel, Outlook).
  • Establishment of excellent interpersonal relations; good communications; ability to negotiate, risk assess, and problem-solve.
  • Ability to work independently, while fostering good working relationships across physical distance and have flexibility and the capacity to handle multiple tasks at once.
  • Ability to travel, if needed.
Responsibilities
  • Oversee the Quality Assurance (QA) PV program for Zoetis.
  • Continuously develop and drive the strategy for quality and regulatory compliance within the program.
  • Provide quality assurance oversight to the global PV program.
  • Be the point of contact for pharmacovigilance QA, ensuring alignment and open communication with US and European Pharmacovigilance teams and other stakeholders of the program.
  • Lead the day-to-day GQC PV operational activities including the scheduling of GQC PV auditing activities (process audits, distributor and Zoetis Country Office audits).
  • Be proficient in performing pharmacovigilance quality assurance audits and inspections of Veterinary Medicine Research & Development (VMRD) PV processes as well as those PV processes which reside outside the VMRD organization (e.g., country offices, distributors).
  • Take a lead QA role in the management of CAPA and deviation activities for pharmacovigilance operations.
  • Participate in government inspections of the pharmacovigilance program and others types of inspections as requested.
  • Provide advice on regulatory and corporate compliance, as well as provide evaluations of current practices that may need improvements.
  • Provide novel approaches to increasing effectiveness of both the GQC group and the quality and compliance of VMRD.
  • Interact effectively with VMRD managers and their staff as an advisor on the interpretation of compliance aspects.
  • Supervise GQC colleagues and contractors who participate in PV audits.
  • Be responsible for meeting company driven deadlines for conducting performance evaluations, colleague development planning, and other required supervisory roles.
  • Assist the GQC Global Lead with budgetary planning and monitoring activities.
  • Where appropriate, assist with staff recruitment and training.
  • Participate in a variety of quality assurance-related activities including staff and project meetings, non-research study document reviews, and consultations with VMRD colleagues.
  • Take a lead role in participating in VMRD meetings, specifically GQC PV meetings, projects and *ad hoc* committees for quality initiatives.
  • Communicate (verbal and written) well with VMRD colleagues, management level individuals, and external parties (e.g., distributors, CROs, vendors).
  • Ability to effectively represent the company or the GQC group in external-facing situations.
Desired Qualifications
  • Master’s degree or equivalent in biology, animal science or other relevant science field.
  • 10+ years working in a research quality assurance field supporting animal health trials.
  • 5+ years in managing people.
  • Experience in conducting pharmacovigilance audits and participating in regulatory inspections.
  • Experience in working with pharmacovigilance databases.
  • Proficiency in the understanding of current regulatory requirements regarding the quality of research for registration of animal products in major global markets.
  • Proficiency in performing quality assurance audits and inspections of non-clinical and clinical veterinary product studies and reports (including protocols, data/data listings, statistics, master study files, final study reports, clinical investigator study sites and in-phase inspections) and of facilities, CROs and processes that support those studies.

Zoetis focuses on animal health by discovering, developing, manufacturing, and selling a variety of medicines and vaccines for animals. Their products cater to both companion animals, like dogs and cats, and livestock, including cattle and poultry. For companion animals, Zoetis offers vaccines, treatments for parasites, and skin care products. For livestock, they provide vaccines, anti-infectives, and medicated feed additives. The company stands out from competitors by heavily investing in research and development to create new products and by maintaining a strong global presence, reaching customers in over 100 countries. Zoetis aims to improve animal health and well-being through its diverse product offerings.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Parsippany-Troy Hills, New Jersey

Founded

1952

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing pet telemedicine boosts Zoetis' companion animal segment.
  • Precision livestock farming enhances productivity, benefiting Zoetis' livestock segment.
  • mRNA vaccine technology offers new product development opportunities for Zoetis.

What critics are saying

  • Alternative proteins may reduce demand for traditional livestock products, impacting Zoetis.
  • Generic competition pressures Zoetis' pricing and market share.
  • Regulatory scrutiny on antibiotics could limit Zoetis' anti-infective market.

What makes Zoetis unique

  • Zoetis leads in animal health with a diverse portfolio of medicines and vaccines.
  • Strong global presence in over 100 countries enhances Zoetis' market reach.
  • Focus on innovation and R&D drives Zoetis' competitive edge in animal health.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Company News

PharmaData
Jun 6th, 2025
Zoetis Highlights Environmental and Social Impact in 2024 Update

Zoetis, a global leader in animal health, has released its 2024 Sustainability Progress Update, titled "Advancing Sustainability in Animal Health for a Better Future," marking the fifth consecutive year the company has reported on its purpose-driven sustainability strategy.

Vettimes
Apr 24th, 2025
Zoetis to host VN parasitology CPD event

Zoetis to host VN parasitology CPD event.

PYMNTS
Apr 17th, 2025
How To Manage Risks When Employees Use Ai Secretly For Work

Employees who use generative artificial intelligence tools in the workplace without company approval or oversight — a practice known as “bring your own AI’ or BYOAI — could introduce risks into the enterprise, according to MIT researchers. “Make no mistake, I’m not talking theory here,” said Nick van der Meulen, a research scientist at MIT’s [] The post How to Manage Risks When Employees Use AI Secretly for Work appeared first on PYMNTS.com.

MarketBeat
Mar 11th, 2025
Clare Market Investments LLC Makes New $670,000 Investment in Zoetis Inc. (NYSE:ZTS)

Clare Market Investments LLC makes new $670,000 investment in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Mar 10th, 2025
Raymond James Financial Inc. Makes New $196.65 Million Investment in Zoetis Inc. (NYSE:ZTS)

Raymond James Financial Inc. makes new $196.65 million investment in Zoetis Inc. (NYSE:ZTS).